Cabecera

Tipo Convocatoria: JOB OFFERS

Información de la Convocatoria

23-282_SS_CR Senior Statistician - Infections and Cancer (UNIC II)

Presentación de Solicitudes

Desde: 29/11/2023 0:00 (UTC+01:00) Bruselas, Copenhague, Madrid, París

Hasta: 21/01/2024 23:59 (UTC+01:00) Bruselas, Copenhague, Madrid, París

Información:

 

Senior Statistician - Infections and Cancer (UNIC II)

Ref.: 23-282_R_CR

 

About the research group

The Unit of Information and Interventions in Infections and Cancer (UNIC II) has long-standing expertise in the prevention of HPV infections and cervical cancer. It facilitates information for decision-making bodies and enables public health interventions both nationally and internationally. UNIC II is recognized for conducting high-quality research to improve the prevention of cancers associated with HPV infection.


European PartnERship to Contrast HPV (PERCH) is a European Union funded project that will involve 18 European countries. The General Objective of PERCH is to contribute to the implementation of Europe’s Beating Cancer Plan, which aims to support Member States’ efforts to extend the roll-out of routine HPV vaccination to eliminate cervical cancer and other cancers caused by HPV in the coming decade. PERCH starts from the analysis of the context with respect to how HPV vaccination and HPV screening are implemented and monitored in all participating countries; determinants of vaccination hesitation will then be analysed in order to increase knowledge and awareness, to target population on the benefits of the vaccine up-take; training activities will also be provided for health personnel on vaccination communication and finally before the end of the Joint Action (JA), MSs will be supported to launch large-scale human papillomavirus vaccination campaigns.

 

About the role

We are looking for a candidate to perform the statistical analysis of HPV vaccine coverage and other health indicators for HPV cancer prevention within the PERCH project. Particularly, the tasks to be carried out are:

   - Statistical analysis of HPV vaccine coverages based on PERCH data
   - Statistical analysis of other health indicators for HPV cancer prevention within the project
   - Acquiring, interpreting and sharing results of PERCH
   - Preparing follow-up reports and deliverables according to the PERCH Project Schedule in coordination with the researchers of the UNIC II
   - Preparing and attending PERCH online and face-to-face coordination meetings
   - Coordinating and establishing synergies between PERCH and other projects within UNIC II

 

Job requirements

Professional experience

  • Research and/or project management in collaborative projects


Education and training

  • A Bachelor's or Master's degree in Statistics, Mathematics, or a Bachelor's degree in Health Sciences with a solid foundation in Statistics


Technical skills

  • Advanced knowledge in MS Office: Word, Excel, PowerPoint, Teams
  • Proficient in R, STATA or equivalent
  • Strong skills in managing scientific projects


Languages

  • Good command of the English language

 

We will value, but not required

  • PhD in Health Sciences
  • Research and/or project management in international collaborative projects
  • Research and/or project management in European Commission funded projects
  • Research in projects related to cervical cancer prevention or vaccines
  • Experience in team coordination and supervision
  • Master's in Public Health
  • Strong foundation in health indicators

 

What do we offer

  • No. of positions: 1

  • Estimated start date: As soon as possible

  • Contract duration: 1 year and 4 months

  • Estimated annual gross salary: 27.000 - 36.000 €

  • You will be part of a multicultural team. We have a fun loving and friendly international work environment.

  • Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.

  • Possibility to work some days in remote - Teleworking

  • 26 working days of holiday per year

  • System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.

  • Paid leave package

  • Benefits of constant training are offered

  • We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

 

Deadline: Please submit your application by 21/01/2024

 

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate.

You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

 

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

 

Observations

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).

This contract has been funded by the European Union’s EU4Health Programme (2021-2027) under the Grant Agreement 101075314.

   
Documentación

Bases de la Convocatoria